[Use of sigetin for the prevention of perinatal mortality and morbidity after the 1st half of complicated pregnancy (experimental and clinical data)].
D000033:Abortion, Threatened / Q000188:drug therapy*; D000818:Animals; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D005313:Fetal Death / Q000517:prevention & control; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D007226:Infant Mortality; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D051381:Rats
D004967:Estrogens
Priemenenie sigetina dlia profilaktiki perinatal'noĭ smertnosti i zabolevaemosti posle oslozhennogo techeniia prevoĭ poloviny beremennosti (éksperimental'nye i klinicheskie dannye.